-
BDRX Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
-
Insider
- Institutional
- Shorts
Biodexa Pharmaceuticals (BDRX)
Company Profile
Quarter (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
13F holders | Current |
---|---|
Total holders | 7 |
Opened positions | 2 |
Closed positions | 10 |
Increased positions | 0 |
Reduced positions | 1 |
13F shares | Current |
---|---|
Total value | 299.96 mm |
Total shares | 141.19 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Cavalry Fund I | 110.56 mm | $279.71 mm |
IOI Ionic Ventures | 18.04 mm | $11.36 mm |
CVI Investments | 10.83 mm | $6.88 mm |
Brio Capital Master Fund | 1.43 mm | $1.39 mm |
Iroquois Capital Management | 327.66 k | $262.00 k |
Contravisory Investment Management | 1.00 k | $282.00 k |
GAMMA Investing | 287.00 | $81.00 k |
Proequities | 0.00 | $0.00 |